Skip to main content
Tech.euFundingExplorerBeta

New Science Ventures

Investor profile

New Science Ventures has backed 7 European tech companies across 11 funding rounds between 2009 and 2026, joining rounds totalling €301M. Most active in Healthtech and Cleantech. Data as of Nov 2026.

Deals
11
distinct rounds
Companies
7
backed
Active span
2009–2026
18 yrs
Total round €
€301M
sum of rounds joined

Deals by year

distinct rounds / year
New Science Ventures — deals by year — interactive chart.
Data table
New Science Ventures — deals by year
20091
20141
20162
20181
20213
20222
20261

Top sectors

by deals
New Science Ventures — top sectors — interactive chart.
Data table
New Science Ventures — top sectors
Healthtech7
Cleantech2
Consumer2
Software1
Semiconductors1

Stages

by deals
New Science Ventures — stages — interactive chart.
Data table
New Science Ventures — stages
Series B6
Debt1
Other1
Series A1
Series C1
Series D+1

Countries

by deals
New Science Ventures — countries — interactive chart.
Data table
New Science Ventures — countries
UK4
Belgium3
France2
Germany1
Netherlands1

Co-investment network

shared rounds
Co-investment network — interactive chart.
New Science Ventures — 11 dealsNew Science VenturesBpifrance — 2 shared deals · click to openBpifranceCR-CP Life Science Fund — 2 shared deals · click to openCR-CP Life Science FundFinancière Fonds Privés — 2 shared deals · click to openFinancière Fonds PrivésFundPlus — 2 shared deals · click to openFundPlusInvest.BW — 2 shared deals · click to openInvest.BWInvestSud — 2 shared deals · click to openInvestSudSRIW Life Sciences — 2 shared deals · click to openSRIW Life SciencesSyncona Partners — 2 shared deals · click to openSyncona PartnersVIVES Louvain Technology Fund — 2 shared deals · click to openVIVES Louvain Technology FundAmadeus Capital Partners — 1 shared deals · click to openAmadeus Capital PartnersBGV — 1 shared deals · click to openBGVBritish Patient Capital’s “Future Fund: Breakthrough” — 1 shared deals · click to openBritish Patient Capital’s “Future Fund: Breakthrough”Cambridge Enterprise — 1 shared deals · click to openCambridge EnterpriseCapnamic Ventures — 1 shared deals · click to openCapnamic VenturesCEA Investissement — 1 shared deals · click to openCEA InvestissementCEA Investment — 1 shared deals · click to openCEA InvestmentDynalim — 1 shared deals · click to openDynalimForbion — 1 shared deals · click to openForbion

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Northsea TherapeuticsNetherlands1€71M
Novadip BiosciencesBelgium3€69M
ParagrafUK1€54M
ISORGFrance2€40M
BioVexUK1€32M
Cambridge EpigenetixUK2€24M
ZeotapGermany1€12M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Northsea TherapeuticsOther€71M2021-12
ParagrafSeries B€54M2022-03
Novadip BiosciencesSeries B€40M2022-11
BioVexSeries D+€32M2009-03
ISORGSeries B€24M2018-09
Cambridge EpigenetixSeries B€19M2016-03
Novadip BiosciencesSeries B€19M2021-11
ISORGSeries C€16M2021-07
ZeotapSeries B€12M2017-01
Cambridge EpigenetixSeries A€4.4M2014-10
← Back to investors